NaviMed Capital
Overview
NaviMed Capital is a Washington, DC-based private equity firm focused exclusively on the healthcare industry. They partner with exceptional management teams to build compelling businesses, providing capital to support both organic and inorganic growth. NaviMed invests in fast growing lower middle-market healthcare businesses that are poised to benefit from the reform and technology innovation forces reshaping the healthcare industry. The firm specializes in acquiring businesses that provide business process outsourcing services to hospitals and other healthcare providers, health insurers, and the pharmaceutical and medical device industries.
Key People
Brian Canann
Managing Director Operating Partner Co-founder
Ryan Ross
Managing Director
Kelley Kendle
Operating Partner
Josh Boylan
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NaviMed Capital based?
NaviMed Capital is headquartered in Rosslyn, Virginia, United States.
When was NaviMed Capital founded?
NaviMed Capital was founded in 2011.
How many portfolio companies does NaviMed Capital have?
NaviMed Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in NaviMed Capital's portfolio?
Specific portfolio company names for NaviMed Capital are not publicly available on Caplight.
What was NaviMed Capital's most recent investment shown here?
Most recent investment information for NaviMed Capital is not publicly available on Caplight.
What sectors does NaviMed Capital focus on?
NaviMed Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does NaviMed Capital focus on?
NaviMed Capital typically invests at the Mid stage.